CVE-2013-2123: The Node access user reference module 6.x-3.x before 6.x-3.5 and 7.x-3.x before 7.x-3.10 for Drupal does not p
CVE-2013-2123 is a medium-severity flaw (CVSS 5.8) affecting nodeaccess userreference module. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
The Node access user reference module 6.x-3.x before 6.x-3.5 and 7.x-3.x before 7.x-3.10 for Drupal does not properly restrict access to content containing a user reference field when the author update/delete grants are enabled and the author's user account is deleted, which allows remote attackers to modify the content via unspecified vectors.
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 5.8 (Medium) |
| EPSS exploit chance | 1.3% (top 29%) |
| CISA exploited list | No |
| Weakness | CWE-264 |
| Published | 2013-08-28 |
| Last modified | 2026-06-16 |
Last updated 2026-06-16 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2013-2123?
nodeaccess userreference module: downgrade or apply the listed mitigation. Exact commands for each OS are on this page.
Is CVE-2013-2123 being exploited?
CVE-2013-2123 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2013-2123 affect?
CVE-2013-2123 affects nodeaccess userreference module. Severity is medium (CVSS 5.8). The Node access user reference module 6.x-3.x before 6.x-3.5 and 7.x-3.x before 7.x-3.10 for Drupal does not properly restrict access to content containing a user reference field when the author update/delete grants are enabled and the auth
How urgent is CVE-2013-2123?
Priority 38/100. No elevated risk signals yet.